2023 agenda
08:00-09:00
Registration and refreshments
09.00-09.15
Welcome from NICE
Sharmila Nebhrajani OBE, chairman, NICE
09.15-10.00
NICE: meeting the challenges for health and care
What leadership role should NICE play in supporting health and care to overcome challenges such as the elective care backlog and overwhelmed mental health services? How can NICE help the NHS make best use of its resources? How can services under pressure be supported in learning, innovating and improving? How is NICE transforming its approach so that it can provide the leadership the sector needs? How should NICE reflect societal values in its work?
Chair: Sharmila Nebhrajani OBE, chairman, NICE
Speakers: Dr Sam Roberts, chief executive, NICE
Dr Jennifer Dixon, chief executive, The Health Foundation
10.00-10.45
Driving high impact healthtech innovation
Advances in diagnostics, devices and digital technologies are transforming healthcare. In a chaotic marketplace, how does NICE collaborate with patients, the NHS and industry to identify, validate and promote innovations which will support digitally enabled care which aligns with NHS England priorities?
Chair: Richard Vize, journalist and public policy analyst and NICE Conference 2023 chair
Speakers: Mark Chapman, interim director of medical technology and digital evaluation, NICE
Rachel Neaman, non-executive director and business advisor, Neaman Consulting Ltd.
10.45-11.15
Refreshments, networking and interactive stands
NICE evolution: learning systems
NICE impact: focusing on what matters most
NICE advice: useful and useable
11.15-12.00
Real-world data (RWD)
Does RWD deliver results which are significantly different from clinical trials, and what are the implications of RWD for future drug development? NICE is now using RWD-informed rolling appraisals to provide technology assessments which keep pace with changing COVID variants, but there is a lot more NICE could do. How could the COVID approach be scaled up to strengthen the speed and impact of NICE’s work?
Chair: Dr Pall Jonsson, programme director for data and real-world evidence, NICE
Speakers: Dr Janet Valentine, executive director, innovation and research policy, ABPI
Dr Arun Sujenthiran, clinical lead & senior medical director, Flatiron Health UK
Dr Jacoline Bouvy, programme director – medicines evaluation, NICE
Mental health
With services being overwhelmed, particularly for children and young people, how can NICE support services to meet demand, through timely guidance and evaluating mental health apps? What is the role of patient reported outcomes in judging apps’ effectiveness? In the face of such an immense overload, what level of performance is required from digital technology to make it useful? Examples will include services for depression and self-harm.
Chair: Richard Vize, journalist and public policy analyst and NICE Conference 2023 chair
Speakers: Dr Sarah Byron, programme director – health technologies programme, NICE
Prof Stephen Pilling PhD, professor of clinical psychology, Department of Clinical, Education and Health Psychology at University College London
Marie Simons, parent carer and NICE committee lay member
Digital living guidelines
Is there a trade-off between quality and speed? Healthcare teams need guidelines which tackle the issues that matter, are delivered quickly, are easily accessible and easy to implement. NICE’s ambition is to update recommendations on key topics within 3 to 6 months of practice-changing evidence emerging. This session will explore how we are piloting this new approach, discuss how to manage any trade-off between speed and quality and invite ideas about how we could improve our guidelines.
Chair: Prof Jonathan Benger, chief medical officer and interim director of the centre for guidelines, NICE
Speakers: Prof Manisha Kumar, chief medical officer, NHS Greater Manchester
Shaun Rowark, associate director- data access and analysis, NICE
12.05-12.50
Life sciences
How do we ensure the UK is an attractive place for the life sciences industry to do business and the UK is delivering the solutions the NHS needs? How does the UK balance its robust approach to pricing with R&D support, such as working with the NHS on clinical trials and the collection of real-world data?
Chair: Jeanette Kusel, director, NICE Advice, NICE
Heather Hobson, head of regulation and access innovation and growth, Office for Life Sciences
Lily Tang, deputy director, MedTech innovation, NHS England
Leslie Galloway, chairman, EMIG
New models of care - a focus on virtual wards
New ways of working such as virtual wards and patient-initiated follow-ups could deliver big improvements in productivity and patients’ quality of life. But the evidence supporting innovations in care delivery is often poor and implementation is hard in a system under pressure. We will discuss the evidence on virtual wards from our deep dive over recent months, look at how we can improve evidence around other potential game-changers, and debate how to make implementation manageable and successful.
Chair: Mark Salmon, programme director information resources, NICE
Speakers: Tara Donnelly, founder, Digital Care
Prof Mary Dixon-Woods, director of THIS Institute, University of Cambridge
Dr Bushra Alam, acute medicine consultant, Salford Royal Hospital and the Greater Manchester clinical lead for virtual wards.
Making place-based integrated care a reality
How does NICE help the health and care system build place-based care around people rather than institutions? How does integrated care manage population health and reduce health inequalities?
Chair: Richard Vize, journalist and public policy analyst and NICE Conference 2023 chair
Speakers: Tony Cooke, chief officer, Health Partnerships, Leeds City Council and chief operating officer, Leeds Academic Health Partnership.
Prof Joe Rafferty CBE, chief executive, Mersey Care NHS Foundation Trust
Amanda Sullivan, chief executive, NHS Nottingham and Nottinghamshire ICB
12.50-13.45
Refreshments, networking and interactive stands
13.45-14.30
Liberating data – in conversation with Professor Ben Goldacre
Improving connections between the vast datasets across healthcare, industry and research could deliver major benefits in patient outcomes, health service management and economic growth, while the pandemic showed the potential for gathering, analysing and acting on data in almost real-time. What needs to change to deliver on this extraordinary potential? Richard Vize leads a conversation with Prof Ben Goldacre, director of the Bennett Institute for Applied Data Science, University of Oxford, with plenty of audience engagement.
Chair: Richard Vize, journalist and public policy analyst and NICE Conference 2023 chair
Speaker: Prof Ben Goldacre, director of the Bennett Institute for Applied Data Science, University of Oxford
Supporting implementation
How can NICE best support the health and care system users to implement its guidance, improve health outcomes and make the best use of resources? This will be an opportunity for the audience to tell NICE about what more they need from us to do their jobs.
Chair: Dr Clare Morgan, director of implementation and partnerships, NICE
Speakers: Jane Scattergood Queen’s Nurse HonMFPH, director of health and care integration for South Cumbria, Lancashire & South Cumbria Integrated Care Board
Dr Fiona Lemmens, associate medical director for transformation and deputy medical director NHS Cheshire and Merseyside Integrated Care System
Prof Gary A Ford, chief executive officer, Health Innovation Oxford and Thames Valley, Health Innovation Networks and NICE
Innovation in action
Case studies highlighted by NICE, presented by the health and care staff who delivered them, to show how implementing guidance leads to innovations in care which benefit patients.
Chair: Annie Coppel, associate director, NICE
Speakers: Dr Emma Kain, consultant in public health | screening and immunisations lead, NHS England South West
Lucy Bond, screening and immunisation manager, NHS England – South West
Helen Pratt, project manager, Dementia United, Greater Manchester Integrated Care Partnership
Kelly Broad, deputy chief pharmacist, Cambridgeshire & Peterborough ICS
14.35-15.20
Medicines evaluation
With many more medicines coming through for evaluation, NICE is piloting new approaches to ensure decisions are timely, appraisals are proportionate, and that NICE has the capability to evaluate increasing complex medicines that may be disruptive to current methods. How should NICE further develop its approaches to guidance development? How are changes to NICE’s evaluation of treatments for the most severe conditions benefitting patients? What’s on the horizon for future modular updates to NICE’s methods of evaluation? What role can the HTA Lab play in developing NICE’s future methods?
Chair: Helen Knight, director of medicines evaluation, NICE
Speakers: Jenniffer Prescott, programme director – health technology assessment process and operations, NICE
Peter Wheatley Price, market access & pricing director UK, Takeda UK Ltd
Dalia Dawoud, associate director – research, NICE
Paul Catchpole, director of value and access policy, ABPI
Healthcare and net zero
The NHS has a roadmap to be net zero by 2040. How does the health service account for environmental impact in its management and care? What trade-offs are tolerable between financial and environmental costs? Can a course of care ever be denied on environmental grounds? Should net zero drive NICE’s topic choices? Could NICE guidelines deliver better patient and environmental outcomes, such as by focusing on prevention? How does NICE start to thread net zero through healthcare guidance so that it becomes everyone’s responsibility?
Chair: Hugh Montgomery, professor of intensive care medicine, University College London; Lancet Countdown on Health and Climate Change
Speakers: Dame Jackie Daniel, chief executive, Newcastle upon Tyne NHS Foundation Trust
Dr Elaine Mulcahy, director, UK Health Alliance on Climate Change
Dr Nick Crabb, interim director, science, evidence and analytics, NICE
Health inequalities
How do we address health inequalities in NICE guidance? How do we ensure the voices of patients and the public shape our guidelines, rather than just have a chance to comment on them. How do we involve stakeholders in shaping implementation and measuring impact to ensure guidance narrows rather than exacerbates inequalities?
Chair: Prof Bola Owolabi, director, National Healthcare Inequalities Improvement Programme, NHS England
Speakers: Rachel Johns, regional director – North East & Yorkshire, OHID and NHSE
Deborah O’Callaghan, associate director and health inequalities lead, NICE
Dr Andrew Furber, regional director, OHID North West and regional director of Public Health, NHSE NW, Department of Health and NHS England
15.20-15.40
Refreshments, networking and interactive stands
15.40-16.50
What you said, what we’ll do
Hybrid futures
Technological advances are eroding the distinctions between clinicians and artificial intelligence, and between medtech and pharmaceuticals. AI, medical devices and pharmaceuticals are coming together to form hybrid therapies which can diagnose and treat without human intervention, while working with AI technology will be as natural to the next generation of clinicians as working with a colleague.
What technologies are on the horizon, what are the challenges in deciding what is safe and effective in this new environment, and how does the current NHS approach to digital, medtech and clinical training need to change to exploit these possibilities?
Chair: Richard Vize, journalist and public policy analyst and NICE Conference 2023 chair
Speakers: Dr Sam Roberts, chief executive, NICE
Prof Partha Kar, national speciality advisor, Diabetes in the NHS
Prof David Robertson, professor, School of Informatics, University of Edinburgh and co-director of Health Data Research UK, Scotland node
Prof Christopher Yau, professor of artificial intelligence, University of Oxford and Health Data Research UK